# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Frontotemporal dementia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 72 results.
Intranasal Oxytocin for Frontotemporal Dementia
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: Aug 24, 2017
Disease(s): Frontotemporal Dementia
Intervention(s): Syntocinon
Locations: UCLA, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Columbia University Medical Center, New York, New York, United States
University of Washington, Seattle, Washington, United States
... and 7 other locations.
A Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia
Status: Not yet recruiting
Last Changed: May 06, 2020
First Received: May 05, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): AL001, Placebo
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: Feb 26, 2015
Disease(s): Familial Frontotemporal Dementia
Locations: University of California, San Francisco, Memory and Aging Center, Department of Neurology, San Francisco, California, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Harvard University, Charlestown, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
... and 4 other locations.
Intranasal Insulin in Frontotemporal Dementia (FTD)
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Oct 04, 2019
Disease(s): Frontotemporal Dementia, Behavioral Variant
Intervention(s): Novolin-R insulin
Locations: HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Aug 10, 2016
Disease(s): Frontotemporal Dementia (FTD)
Intervention(s): Lithium Carbonate, Placebo
Locations: Columbia University Medical Center, New York, New York, United States
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin Mutation
Status: Recruiting
Last Changed: Apr 19, 2019
First Received: Aug 17, 2018
Disease(s): Healthy, Frontotemporal Dementia
Intervention(s): AL001, Placebo
Locations: University of Alabama, Birmingham, Alabama, United States
UCSF, San Francisco, California, United States
Study site, Orlando, Florida, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
... and 4 other locations.
A Study to Evaluate Safety of Long-term AL001 Dosing in FTD Patients
Status: Recruiting
Last Changed: Oct 25, 2019
First Received: Jun 17, 2019
Disease(s): Frontotemporal Dementia
Intervention(s): AL001
Locations: University of Alabama, Birmingham, Alabama, United States
UCSF, San Francisco, California, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Lawson Health Research Institute, St. Joseph's, London, Ontario, Canada
... and 7 other locations.
Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia
Status: Recruiting
Last Changed: Jun 21, 2019
First Received: Dec 13, 2017
Disease(s): Primary Progressive Aphasia
Intervention(s): Evidence-Based Treatment
Locations: Cognitive Neurology and Alzheimer's Disease Center - Northwestern University, Chicago, Illinois, United States
Optimization of Electrical Stimulation Approaches in Three Primary Progressive Aphasia Variants
Status: Recruiting
Last Changed: Nov 21, 2019
First Received: Mar 25, 2019
Disease(s): Primary Progressive Aphasia
Intervention(s): High-definition active tDCS (HD-tDCS) + Language/Cognitive Intervention(s), Sham + Language/Cognitive Intervention(s)
Locations: Johns Hopkins Hospital, Baltimore, Maryland, United States
The Effects of a Multimodal Approach for the Treatment of Primary Progressive Aphasia
Status: Recruiting
Last Changed: Jan 22, 2020
First Received: Dec 05, 2019
Disease(s): Primary Progressive Aphasia
Intervention(s): Active tDCS, Placebo tDCS, Language training, Unstructured cognitive training
Locations: IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, BS, Italy